You are currently logged into
Cancer Health Directory - My Account or Log Out
Cancer Health Cancer Health
  • Home
  • News
    • News
    • Newsfeed
    • Treatment News
    • Features
    • Opinions
    • Conferences
    • Slideshows
    • Cancer Health TV
    • By Author
    • RSS Links
  • Cancer Basics
    • Cancer 101
    • Newly Diagnosed
    • Living with Cancer
    • Cancer Treatment
    • Cancer Medications
    • Breast Cancer
    • Colon Cancer
    • Liver Cancer
    • Lung Cancer
    • Prostate Cancer
    • More Types of Cancer
    • Resources
  • Hot Topics
    • Coronavirus (COVID-19)
    • Health Equity
    • Cancer Treatment
    • Car-T Therapy
    • Caregivers
    • Chemotherapy
    • Immunotherapy
    • Marijuana
    • Mental Health
    • Quality of Life
  • Magazine
    • Magazine
    • Current Issue
    • Archives
    • Digital Editions
    • Cancer Health Focus
    • Bulk Subscriptions
    • Email Newsletters
  • Blogs
    • Blogs
    • Recent Posts
    • Browse Bloggers
    • RSS Links
  • Community
    • Cancer Health Stories
    • Cancer Health Forums
    • Ask Cancer Health
    • Polls
    • Surveys
    • Quizzes
    • Calendar
    • Volunteer Jobs
    • Bookstore
    • Amazon Store
  • About Us
    • About Us
    • Masthead
    • Advertise
    • Awards
    • Contact Us
  • Facebook
  • Twitter

© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

© 2021 Smart + Strong.
All Rights Reserved.
Terms of use and
Your privacy.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.

Advertisement

Share


Twitter
Facebook
Pinterest
Tumblr
Email

#Bavencio

Tweet
  • Share

Bavencio

FDA Approves Bavencio for Bladder Carcinoma Maintenance Treatment

The immunotherapy is now approved for people whose cancer has not progressed on platinum-based chemotherapy.

Bavencio Plus Inlyta Gets Green Light for Kidney Cancer

FDA approves immunotherapy plus targeted therapy combo for initial treatment of advanced renal cell carcinoma.

Lori Wood, MD

Checkpoint Combos Improve Advanced Kidney Cancer Outcomes

Keytruda and Bavencio may soon join Opdivo/Yervoy as first-line treatment options for advanced renal cell carcinoma.

Checkpoint Immunotherapy Combos Reduce Kidney Cancer Progression

Bavencio or Keytruda plus targeted therapy slowed disease progression in Phase III studies.

James Allison, PhD, Tasuku Honjo, MD, PhD

Cancer Immunotherapy Researchers Win Nobel Prize

James Allison and Tasuku Honjo recognized for immune checkpoint discoveries.

Red blood cells

Immunotherapy

Antibodies

Researchers Find New Immune Checkpoint—and a Drug to Block It

The experimental antibody BAY1905254 targets the newly discovered checkpoint ILDR2.

White blood cells

ASCO and NCCN Issue Guidelines on Managing Immunotherapy Side Effects

Taking the brakes off the immune system can lead to excessive responses that harm healthy organs and tissue.

Advertisement

Stay Logged In?

You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.

You Have Been Logged Out

Click here to log back in.